3,840
Views
11
CrossRef citations to date
0
Altmetric
Original article

Early detection of type 2 diabetes in socioeconomically disadvantaged areas in Stockholm – comparing reach of community and facility-based screening

ORCID Icon, , , , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Article: 1795439 | Received 13 Apr 2020, Accepted 07 Jul 2020, Published online: 04 Aug 2020

References

  • International Diabetes Federation. IDF diabetes atlas; 2019 [cited 2019 Dec 9]. Available from: https://diabetesatlas.org/en/sections/proven-and-effective-actions.html
  • Hälso- och Sjukvårdsförvaltningen. Diabetes i primärvården 2013; 2014. Available from: https://www.vardgivarguiden.se/globalassets/utbildning-och-utveckling/vardutveckling/fokusrapporter/diabetes-inom-primarvarden-2013.pdf?IsPdf=true
  • Bennet L, Groop L, Lindblad U, et al. Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes. Prim Care Diabetes. 2014;8:231–10.
  • Wändell PE, Gåfvels C. High prevalence of diabetes among immigrants from non-European countries in Sweden. Prim Care Diabetes. 2007;1:13–16.
  • Tao W, Bruce D, Burström B Områdesskillnader i sjukdomsförekomst Stockholms län 2006–2011; 2015. Available from: http://dok.slso.sll.se/CES/FHG/Jamlik_halsa/Rapporter/Omradesskillnader-i-sjukdom.pdf
  • Statistics Sweden. Care need index. [ cited 2019]. Available from: https://www.scb.se/contentassets/eb0efb72e6bc422bb77503973b423531/cni-produktblad.pdf
  • Simmons D, Zgibor JC. Should we screen for type 2 diabetes among asymptomatic individuals? Yes. Diabetologia. 2017;60:2148–2152.
  • Harris R, Donahue K, Rathore SS, et al. Screening adults for type 2 diabetes: a review of the evidence for the US preventive services task force. Ann Intern Med. 2003;138:215–229.
  • American Diabetes Association. Standars of medical care in diabetes – 2019. Diabetes Care 2019; [ cited 2019]. Available from: https://care.diabetesjournals.org/content/42/Supplement_1
  • Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279–2290.
  • Socialstyrelsen. Nationella riktlinjer för diabetesvård; 2018 [cited 2019]. Available from: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/nationella-riktlinjer/2018-10-25.pdf
  • Saaristo T, Peltonen M, Lindström J, et al. Cross-sectional evaluation of the Finnish diabetes risk score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2:67–72.
  • Khunti K, Mani H, Achana F, et al. Systematic review and meta-analysis of response rates and diagnostic yield of screening for type 2 diabetes and those at high risk of diabetes. PLoS One. 2015;10:e0135702.
  • Eborall H, Davies R, Kinmonth A-L, et al. Patients’ experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ. 2007;335:490.
  • Vähäsarja K, Kasila K, Kettunen T, et al. ‘I saw what the future direction would be’: experiences of diabetes risk and physical activity after diabetes screening. Br J Health Psychol. 2015;20:172–193.
  • Feldman AL, Griffin SJ, Fhärm E, et al. Screening for type 2 diabetes: do screen-detected cases fare better? Diabetologia. 2017;60:2200–2209.
  • Man Ying Lee C, Colagiuri S. Population approaches for detecting glucose disorders. Curr Diabetes Rev. 2016;12:42–50.
  • Millard AV, Graham MA, Mier N, et al. Diabetes screening and prevention in a high-risk, medically isolated border community. Front Public Health. 2017;5:135.
  • Misra R, Fitch C, Roberts D, et al. Community-based diabetes screening and risk assessment in rural West Virginia. J Diabetes Res. 2016;2016:1–9.
  • Chatterjee R, Narayan KMV, Lipscomb J, et al. Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care. 2013;36:1981–1987.
  • Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008;336:1180–1185.
  • Shahim B, Hasselberg S, Boldt-Christmas O, et al. Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje. Eur J Prev Cardiol. 2018;25:1990–1999.
  • Davidson MB, Duran P, Lee ML. Community screening for pre-diabetes and diabetes using HbA1c levels in high risk African Americans and Latinos. Ethn Dis. 2014;24:195.
  • Montesi L, Caletti MT, Marchesini G. Diabetes in migrants and ethnic minorities in a changing world. World J Diabetes. 2016;7:34.
  • Graetz V, Rechel, B, Groot, W. Utilization of health care services by migrants in Europe-a systematic literature review. British medical bulletin; 2017;121:5–18.
  • Willis A, Roshan M, Patel N, et al. A community faith centre based screening and educational intervention to reduce the risk of type 2 diabetes: a feasibility study. Diabetes Res Clin Pract. 2016;120:73–80.
  • Kwan BM, McGinnes HL, Ory MG, et al. RE-AIM in the real world: use of the RE-AIM framework for program planning and evaluation in clinical and community settings. Front Public Health. 2019;7:345.
  • Shaghaghi A, Bhopal RS, Sheikh A. Approaches to recruiting ‘hard-to-reach’populations into research: a review of the literature. Health Promot Perspect. 2011;1:86.
  • Marlow L, McBride E, Varnes L, et al. Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England. BMC Women’s Health. 2019;19:38.
  • Marlow LA, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority women: a qualitative study. J Fam Plann Reprod Health Care. 2015;41:248–254. .
  • Briant KJ, Espinoza N, Galvan A, et al. An innovative strategy to reach the underserved for colorectal cancer screening. J Cancer Educ. 2015;30:237–243.
  • Guwatudde D, Absetz P, Delobelle P, et al. Study protocol for the SMART2D adaptive implementation trial: a cluster randomised trial comparing facility-only care with integrated facility and community care to improve type 2 diabetes outcomes in Uganda, South Africa and Sweden. BMJ Open. 2018;8:e019981.
  • Karolinska Institutet. SMART2D; 2019. Available from: http://ki.se/en/phs/smart2d
  • Karolinska Institutet. Research appendix program 4D; 2015. [cited 2019]. Available from: https://vardgivarguiden.se/globalassets/utveckling/aktuella-projekt/program-4-d/forskningsprojekt_program4d.pdf
  • Moher D, Liberati, A, Tetzlaff, J. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
  • Andersson R. Reproducing and reshaping ethnic residential segregation in Stockholm: the role of selective migration moves. Geogr Ann. 2013;95:163–187. .
  • Sundquist K, Malmström, M, Johansson, SE, et al. Care need index, a useful tool for the distribution of primary health care resources. J Epidemiol Community Health. 2003;57:347–352.
  • Schwarz PE, Li J, Lindstrom J, et al. Tools for predicting the risk of type 2 diabetes in daily practice. Hormone Metab Res. 2009;41:86–97.
  • Zhang L, Zhang Z, Zhang Y, et al. Evaluation of Finnish diabetes risk score in screening undiagnosed diabetes and prediabetes among US adults by gender and race: NHANES 1999-2010. PLoS One. 2014;9:e97865.
  • Štiglic G, Fijačko N, Stožer A, et al. Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population. Diabetes Res Clin Pract. 2016;120:194–197.
  • Tankova T, Chakarova N, Atanassova I, et al. Evaluation of the Finnish diabetes risk score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract. 2011;92:46–52.
  • Salinero-Fort M, Burgos-Lunar C, Lahoz C, et al. Performance of the Finnish diabetes risk score and a simplified Finnish diabetes risk score in a community-based, cross-sectional programme for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in Madrid, Spain: the SPREDIA-2 study. PLoS One. 2016;11:e0158489.
  • Statistiska centralbyrån (SCB). [ cited 2019]. Available from: http://www.statistikdatabasen.scb.se/pxweb/sv/ssd/?rxid=f45f90b6-7345-4877-ba25-9b43e6c6e299
  • Meeks KAC, Freitas-Da-Silva D, Adeyemo A, et al. Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Intern Emerg Med. 2016;11:327–340.
  • Klimentidis YC, Abrams M, Wang J, et al. Natural selection at genomic regions associated with obesity and type-2 diabetes: East Asians and sub-Saharan Africans exhibit high levels of differentiation at type-2 diabetes regions. Hum Genet. 2011;129:407–418.
  • Tekola-Ayele F, Adeyemo AA, Rotimi CN. Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa. Prog Cardiovasc Dis. 2013;56:251–260.
  • Chan JCN, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Jama. 2009;301:2129–2140.
  • Peer N, Kengne A-P, Motala AA, et al. Diabetes in the Africa Region: an update. Diabetes Res Clin Pract. 2014;103:197–205.
  • Tuggle AC, Cohen JH, Crews DE. Stress, migration, and allostatic load: a model based on Mexican migrants in Columbus, Ohio. J Physiol Anthropol. 2018;37:28.
  • Mendenhall E. Beyond comorbidity: a critical perspective of syndemic depression and diabetes in cross-cultural contexts. Med Anthropol Q. 2015. DOI:10.1111/maq.12210
  • Shoenberg D, Stoller K. Situating stress: lessons from lay discourses on diabetes. In: Hahn RA, Inhorn MC, editors. Anthropology and public health - bridging differences in culture and society. 2005;19(2):171–193.
  • Eriksson A-K, van den Donk M, Hilding A, et al. Work stress, sense of coherence, and risk of type 2 diabetes in a prospective study of middle-aged Swedish men and women. Diabetes Care. 2013;36:2683–2689.
  • Andersen JH, Whyte SR. Measuring risk, managing values: health technology and subjectivity in Denmark. Anthropol Med. 2014;21:265–276.
  • Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38:1449–1455.
  • Colagiuri S. Epidemiology of prediabetes. The Medical Clinics of North America. 2015;20:299–307.
  • Hofmann B. Back to basics: overdiagnosis is about unwarranted diagnosis. American Journal of Epidemiology; 2019;188(10):1812–1817.
  • Sachs L. Is there a pathology of prevention? The implications of visualizing the invisible in screening programs. Cult Med Psychiatry. 1995;19:503–525.
  • Smith-Morris C The chronicity of life, the acuteness of diagnosis. In: MLS-M C, editor. Chronic conditions, fluid states: chronicity and the anthropology of Illness. New Brunswik: Rutgers University Press; 2010; p. 21–37.
  • Timm L, Daivadanam M, Lager A, et al. “I did not believe you could get better”—reversal of diabetes risk through dietary changes in older persons with prediabetes in region Stockholm. Nutrients. 2019;11:2658.
  • Janghorbani M, Adineh H, Amini M. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome. The Review of Diabetic Studies: RDS. 2013;10:283.
  • Kulkarni M, Foraker RE, McNeill AM, et al. Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants. Diabetes Obesity Metab. 2017;19:1260–1266.
  • Mavrogianni C, Lambrinou C-P, Androutsos O, et al. Evaluation of the Finnish diabetes risk score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study. Diabetes Res Clin Pract. 2019;150:99–110.
  • Nieto-Martinez R, González-Rivas JP, Aschner P, et al. Transculturalizing diabetes prevention in Latin America. Ann Glob Health. 2017;83:432–443.
  • Jølle A, Midthjell K, Holmen J, et al. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study. BMJ Open Diabetes Res Care. 2019;7:e000769.
  • Agarwal G, Guingona MM, Gaber J, et al. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population. BMC Public Health. 2019;19:1169.
  • Sheringham J, Simms I, Riha J, et al. Will chlamydia screening reach young people in deprived areas in England? Baseline analysis of the English National Chlamydia Screening Programme delivery in 2008. Sex Transm Dis. 2011;38:677–684.
  • Dev S, Jain T, P. S, et al. Risk factor assessment and screening for diabetes in field practice area of a private medical college in Thiruvallur district of Tamil Nadu. Int J Community Med Public Health. 2017;4:2670–2673.
  • Cooke R, Jones A. Recruiting adult participants to physical activity intervention studies using sport: a systematic review. BMJ Open Sport Exerc Med. 2017;3:e000231.
  • Absetz P, Van Olmen J, Guwatudde D, et al. SMART2D—development and contextualization of community strategies to support self-management in prevention and control of type 2 diabetes in Uganda, South Africa, and Sweden. Transl Behav Med. 2020;10:25–34.